Boon Industries Announces Effective Date of Form 10 Registration Statement
Larry A. Watts
4 min read
The Company is now subject to the reporting requirements of the Securities Exchange Act of 1934
SACRAMENTO, Calif., February 24, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Boon Industries, Inc. (OTC PINK: BNOW) (“Boon” or the “Company”), an innovative bioscience company providing solutions that benefit people and the planet, is pleased to announce today that its registration statement on Form 10 filed with the Securities and Exchange Commission (the “SEC”) became effective February 14, 2022. As a result, the Company is now subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, and is required to file annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q and periodic reports on Form 8-K.
Filing Form 10 provides investors with detailed information about the company and its operations, including audited financial statements. This transparency should help the investing public make more informed investment decisions with respect to the Company’s equity. Form 10 may be viewed in its entirety at www.sec.gov under the name of Boon Industries, Inc.
“We believe the effectiveness of our Form 10 registration statement is a watershed event for Boon and its shareholders,” said Justin Gonzalez, president and CEO of Boon Industries. “We sincerely appreciate the patience of our partners and investors as we bring this company into an important new phase of expanded production and with the sunlight of transparency to record and celebrate our successes.
“Overall, this progress aligns with Boon’s commitment to a new phase for the company in which we simultaneously pursue new market opportunities and transparency,” Gonzalez added.
About Boon Industries
Boon Industries, Inc. (OTC: BNOW) is an innovative bioscience company that delivers solutions that benefit people and the planet. At the heart of Boon’s product offering is DiOx+™, a chlorine dioxide disinfectant sterilizer. Chlorine Dioxide has been approved by OSHA, FDA, EPA and DOT. DiOx+ kills harmful pathogens without harmful toxic exposure to the user or the environment. The chemical formulas and proprietary processes behind DiOx+ make it ideal for sterilizing critical and high-value medical equipment and for disinfecting air and surfaces in laboratory and hospital environments. DiOx+ helps protect agricultural crops from disease, is used in water treatment plants, and helps reduce operating costs in warehouses, distribution centers, and e-commerce support facilities. The introduction of DiOx+ to the US market follows 12 years of using chlorine dioxide in global markets under the leadership of Boon CEO Justin Gonzalez. DiOx+ delivers on Boon’s promise to provide the most effective and affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon’s manufacturing facility and corporate headquarters in Grass Valley, California.
Safe Harbor for Forward-Looking Statements: This press release contains forward-looking statements that are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words that indicate that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by words such as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will” or “plans”. Because forward-looking statements are based on assumptions and address future events and conditions, they, by their very nature, involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company does not guarantee that actual results will meet management’s expectations. The risks, uncertainties and other factors involved in forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information contained in this press release are reasonable, undue reliance should not be placed on such information, which speaks only as of the date of this press release, and no assurance can be given that such events will occur within the time disclosed or not at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
Please note that from time to time the Company may post new information on its website. boonindustries.comor via his current social media accounts below:
LinkedIn: https://www.linkedin.com/company/boon-industries
Twitter: https://twitter.com/boonindustries
The company’s most recent investor presentation is available at the following link:
Company details
Boon Industries, Inc.
www.boonindustries.com
[email protected]
Investor Relations & Financial Media
Integrity Media Inc.
Toll Free: (888) 216-3595
